Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Darke

Showing results (151-160 of 215) with videos related to

Pageof 22
Sort By:
Journal of Clinical Pharmacology|March 31, 2007
Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorderDeclan Quinn, Twyla Bode, Joseph L Reiz, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Comparative single dose and steady-state pharmacokinetics of bevantolol in young and elderly subjectsA Selen, A W Kinkel, A C Darke, et al.
Human Immunology|April 1, 1992
Frequency of HLA-DPB1 alleles, including a novel DPB1 sequence, in the Northern Ireland populationD A Savage, D Middleton, F Trainor, et al.
International Journal of Medical Informatics|April 17, 1999
Predicting cytomegalovirus disease after renal transplantation: an artificial neural network approachD Sheppard, D McPhee, C Darke, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|December 1, 1994
Genomic analysis of the F subtypes of human complement factor BI Jahn, J E Mejía, M Thomas, et al.
Experimental and Clinical Immunogenetics|July 8, 1999
Molecular, serological and population studies of the alleles and products of HLA-B*41C Darke, S Winkler, M G Guttridge, et al.
Cancer|September 15, 1994
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer painH Hays, N Hagen, M Thirlwell, et al.
Genetic Testing|June 24, 2006
A high-resolution polymerase chain reaction-sequence-specific primer HLA-B*27 typing set and its application in routine HLA-B27 testingJ Downing, E Coates, J Street, et al.
Tissue Antigens|December 6, 1997
The HLA A1-B8 haplotype extends 6 Mb beyond HLA-A: associations between HLA-A, B, F and 15 microsatellite markersM Worwood, R Raha Chowdhury, K J Robson, et al.
Journal of Clinical Pharmacology|January 1, 1995
Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphoneN Hagen, M P Thirlwell, H S Dhaliwal, et al.
Pageof 22

Showing results (151-160 of 215) with videos related to

Sort By:
Pageof 22
Journal of Clinical Pharmacology|March 31, 2007
Single-dose pharmacokinetics of multilayer-release methylphenidate and immediate-release methylphenidate in children with attention-deficit/hyperactivity disorderDeclan Quinn, Twyla Bode, Joseph L Reiz, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Comparative single dose and steady-state pharmacokinetics of bevantolol in young and elderly subjectsA Selen, A W Kinkel, A C Darke, et al.
Human Immunology|April 1, 1992
Frequency of HLA-DPB1 alleles, including a novel DPB1 sequence, in the Northern Ireland populationD A Savage, D Middleton, F Trainor, et al.
International Journal of Medical Informatics|April 17, 1999
Predicting cytomegalovirus disease after renal transplantation: an artificial neural network approachD Sheppard, D McPhee, C Darke, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|December 1, 1994
Genomic analysis of the F subtypes of human complement factor BI Jahn, J E Mejía, M Thomas, et al.
Experimental and Clinical Immunogenetics|July 8, 1999
Molecular, serological and population studies of the alleles and products of HLA-B*41C Darke, S Winkler, M G Guttridge, et al.
Cancer|September 15, 1994
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer painH Hays, N Hagen, M Thirlwell, et al.
Genetic Testing|June 24, 2006
A high-resolution polymerase chain reaction-sequence-specific primer HLA-B*27 typing set and its application in routine HLA-B27 testingJ Downing, E Coates, J Street, et al.
Tissue Antigens|December 6, 1997
The HLA A1-B8 haplotype extends 6 Mb beyond HLA-A: associations between HLA-A, B, F and 15 microsatellite markersM Worwood, R Raha Chowdhury, K J Robson, et al.
Journal of Clinical Pharmacology|January 1, 1995
Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphoneN Hagen, M P Thirlwell, H S Dhaliwal, et al.
Pageof 22